Farms.com Home   News

US Ethanol, Distillers Grains Exports Partially Rebound in June

The U.S. exported 78.49 million gallons of ethanol and 883,193 metric tons of distillers grains in June, according to data released by the USDA Foreign Agriculture Service on Aug. 5. Exports of both products were up when compared to May.
 
The 78.49 million gallons of ethanol exported in June was up from the 67.53 million gallons of ethanol exported the previous month, but down form 122.33 million gallons exported in June 2019.
 
The U.S. exported ethanol to approximately 44 countries in June. Canada was the top destination for U.S. ethanol at 27.38 million gallons, followed by India at 12.64 million gallons and Mexico at 8.98 million gallons.
 
The value of U.S. ethanol exports was $143.67 million in June, up from $132.8 million in May, but down from $205.41 million in June 2019.
 
The U.S. exported a total of 730.72 million gallons of ethanol during the first six months of 2020 at a value of $1.27 billion, compared to 764 million gallons at a value of $1.21 billon exported during the same period of 2019.
 
The 883,193 metric tons of distillers grains exported in June was up from 601,029 metric tons exported in May, but down from the 956,580 tons exported during June 2019.
 
The U.S. exported distillers grains to nearly three dozen countries in June. Thailand was the top destination, at 208,456 metric tons, followed by Mexico at 97,873 tons and Vietnam at 94,277 tons.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.